BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16402924)

  • 21. Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability.
    Gann P; Chatterton R; Vogelsong K; Dupuis J; Ellman A
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):421-8. PubMed ID: 9184775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor stimulation of human breast cancer cells in culture.
    Osborne CK; Hamilton B; Titus G; Livingston RB
    Cancer Res; 1980 Jul; 40(7):2361-6. PubMed ID: 6966967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of growth factors on proliferation and expression of growth factor receptors in a human lens epithelial cell line.
    Kampmeier J; Baldysiak-Figiel A; de Jong-Hesse Y; Lang GK; Lang GE
    J Cataract Refract Surg; 2006 Mar; 32(3):510-4. PubMed ID: 16631066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells.
    Abukhdeir AM; Blair BG; Brenner K; Karakas B; Konishi H; Lim J; Sahasranaman V; Huang Y; Keen J; Davidson N; Vitolo MI; Bachman KE; Park BH
    Breast Cancer Res Treat; 2006 Sep; 99(1):23-33. PubMed ID: 16541319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human breast cell lines exhibit functional alpha2-adrenoceptors.
    Vázquez SM; Mladovan AG; Pérez C; Bruzzone A; Baldi A; Lüthy IA
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):50-61. PubMed ID: 16292538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of breast cyst fluid on oestrone sulphatase activity in MCF-7 breast cancer cells.
    Erbas H; Lennard TW; Lai LC
    Anticancer Res; 1996; 16(2):833-6. PubMed ID: 8687137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatic acid phosphatase in breast cyst fluid.
    Erbas H; Erten O; Irfanoglu ME
    Malays J Pathol; 2007 Dec; 29(2):95-9. PubMed ID: 19108401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oestradiol and epidermal growth factor in breast cyst fluid.
    Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; James VH
    Anticancer Res; 1989; 9(6):1853-6. PubMed ID: 2627131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of TGF-beta(1-3) in serosal fluid during abdominal surgery and their effect on in vitro human mesothelial cell proliferation.
    Falk P; Bergström M; Palmgren I; Holmdahl L; Breimer ME; Ivarsson ML
    J Surg Res; 2009 Jun; 154(2):312-6. PubMed ID: 19062040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of proliferative and anti-apoptotic effects of HGF, insulin, IGF-1, IGF-2, and EGF in SV40-transformed human corneal epithelial cells.
    Yanai R; Yamada N; Inui M; Nishida T
    Exp Eye Res; 2006 Jul; 83(1):76-83. PubMed ID: 16530761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate.
    Serpero L; Petecchia L; Sabatini F; Giuliani M; Silvestri M; Di Blasi P; Rossi GA
    Immunol Lett; 2006 May; 105(1):61-7. PubMed ID: 16481045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental study of repairing damaged human amniotic epithelial cells with formulated fibrin clot and cell growth factor].
    Qi HB; Li W; Bian DH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):12-5. PubMed ID: 16635320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content.
    Zanardi S; Pensa F; Torrisi R; De Franchis V; Barreca A; Minuto F; Boccardo F
    Int J Cancer; 1994 Dec; 59(6):725-7. PubMed ID: 7989108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control and expression of oestrone sulphatase activities in human breast cancer.
    Pasqualini JR; Chetrite G; Nestour EL
    J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cyst fluid plasmin activity and its effect on TGF-beta2 activation.
    Erbas H; Erten O; Irfanoglu ME
    Cancer Invest; 2008 Feb; 26(1):22-7. PubMed ID: 18181041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration of aluminium in breast cyst fluids collected from women affected by gross cystic breast disease.
    Mannello F; Tonti GA; Darbre PD
    J Appl Toxicol; 2009 Jan; 29(1):1-6. PubMed ID: 18785682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of growth factors on proliferation of normal, borderline, and malignant breast epithelial cells.
    Bhalla V; Joshi K; Vohra H; Singh G; Ganguly NK
    Exp Mol Pathol; 2000 Apr; 68(2):124-32. PubMed ID: 10716915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
    King ML; Adler SR; Murphy LL
    Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioassay of transforming growth factor-beta activity in acidic protein extracts from primary breast cancer specimens.
    Godden J; Porteous C; George WD; Kerr DJ
    Anticancer Res; 1993; 13(2):427-31. PubMed ID: 8517658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.